ArticleTherapeutic advances in medical oncology2026
Clinical management and outcomes of relapsed NSCLC after chemoradiotherapy and durvalumab consolidation: real-world evidence from Germany.
Georg Evers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.